Generon's benegrastim meets in Phase III for CIN

Generon (Shanghai) Corp. Ltd. (Shanghai, China) reported data from a Phase III trial in about 122 women with stage II-IV breast cancer patients receiving

Read the full 245 word article

User Sign In